Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.


We conducted qualitative interviews with encampment residents to explore how mutual support occurred within the social context of encampments.

Original research | 2022
Poverty, Housing
Report | 2022
Policy/Regulatory, Harm reduction, Safer supply
Report | 2022
Harm reduction, Substitution/OAT, Policy/Regulatory, Advocacy

We aimed to test the hypothesis that in-jail MOUD is associated with lower overdose mortality risk post-release.

Original research | 2022
Substitution/OAT, Justice system/law enforcement, Outcomes, Overdose, Mortality
Infographic | 2022
About pharmacists, Wrap-around services, Safer supply, Policy/Regulatory

Due to the coronavirus disease 2019 (COVID-19) pandemic, Health Canada issued an exemption to the Controlled Drugs and Substances Act (CDSA) on March 19, 2020, enabling pharmacists to act as prescr

Original research | 2022
About pharmacists, Policy/Regulatory, Wrap-around services, Safer supply

This research brief describes the first Extension for Community Healthcare Outcomes (ECHO) program focused on first responders and opioids, including the content covered and concomitant popularity

Original research | 2022
Overdose, Social services

The objective of this study was to identify patient and prescription characteristics associated with long-term buprenorphine treatment retention.

Original research | 2022
Substitution/OAT, About PWUD, Barriers and enablers, Outcomes

In order to expand the field’s understanding of care beyond an avowed a-political approach to clinical supervision, we conducted qualitative interviews with staff at Sydney Medically Supervised Inj

Original research | 2022
Overdose, SCS/OPS

We examined how age-related patterns of cocaine and methamphetamine use vary by sexual identity and gender among a national sample.

Original research | 2022
About PWUD, Illegal drugs, 2SLGBTQI+, Stimulants

This study identified patient clinical and sociodemographic characteristics, and, more originally, service use patterns as predictors of death from physical illness or accidental/intentional causes

Original research | 2022
Mortality, About PWUD

This review aimed to assess the application and effectiveness of digital interventions to treat opioid use disorder globally.

Lit review | 2022
Digital health, About PWUD
Guide or handbook | 2021
SCS/OPS, Harm reduction, Policy/Regulatory, Illegal drugs
Rapport | 2022
la surdose, la mortalité
Report | 2022
Overdose, Mortality

Racial/ethnic minoritized patients are less likely to receive OAT compared to non-Hispanic White patients.

Original research | 2022
Equity, Barriers and enablers, About PWUD, Substitution/OAT

To understand patient experience of federal regulatory changes governing methadone and buprenorphine (MOUD) access in Arizona during the COVID-19 pandemic.

Original research | 2022
Policy/Regulatory, About PWUD, Substitution/OAT, Carries/take-home doses

Refine Your Search